To ensure comparability between the two cohorts, propensity score matching (PSM) was conducted to match important baseline factors, including demographic data, creatinine (Cr), sodium (Na), aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, HBV-DNA, international normalized ratio (INR), decompensation status, model for end-stage liver disease (MELD) score, albumin–bilirubin (ALBI) score, Charlson comorbidity index (CCI), and cumulative duration of medication. This evidence concerns the gene ALB and End Stage Liver Disease.